Medi Assist IPO: Co has consistently delivered healthy financial performance with Revenue/EBITDA/PAT growing at CAGR of 25.1%/25.7%/40.8% from FY21- FY23. It holds 17.3% of total TPA premium. It is valued at FY23 P/E & EV/EBITDA multiple of 38.9x & 22.3x
![[IMG]](https://pbs.twimg.com/media/GDsxTpNaoAAQvak?format=jpg&name=360x360)
| Subscribe To Our Free Newsletter |
